| Inactivation of human immunodeficiency virus type 1 by porphyrins AN Vzorov, DW Dixon, JS Trommel, LG Marzilli, RW Compans Antimicrobial Agents and Chemotherapy 46 (12), 3917-3925, 2002 | 147 | 2002 |
| Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian … KSM Skountzou I, Quan FS, Gangadhara S, Ye L, Vzorov A, Selvaraj P, Jacob J ... J Virol 81 (3), 1083-1094, 2007 | 100 | 2007 |
| Virus-like particle and DNA-based candidate AIDS vaccines Q Yao, Z Bu, A Vzorov, C Yang, RW Compans Vaccine 21 (7-8), 638-643, 2003 | 77 | 2003 |
| Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant EV Vassilieva, BZ Wang, AN Vzorov, L Wang, YC Wang, J Bozja, R Xu, ... MBio 2 (1), 10.1128/mbio. 00328-10, 2011 | 67 | 2011 |
| Prevention of HIV-1 infection by phthalocyanines AN Vzorov, LG Marzilli, RW Compans, DW Dixon Antiviral research 59 (2), 99-109, 2003 | 65 | 2003 |
| Sulfonated naphthyl porphyrins as agents against HIV-1 DW Dixon, AF Gill, L Giribabu, AN Vzorov, AB Alam, RW Compans Journal of inorganic biochemistry 99 (3), 813-821, 2005 | 50 | 2005 |
| Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains AN Vzorov, RW Compans Virology 221 (1), 22-33, 1996 | 49 | 1996 |
| Prevention of HIV-1 infection by platinum triazines AN Vzorov, D Bhattacharyya, LG Marzilli, RW Compans Antiviral research 65 (2), 57-67, 2005 | 48 | 2005 |
| Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain L Ye, Z Bu, A Vzorov, D Taylor, RW Compans, C Yang Journal of virology 78 (24), 13409-13419, 2004 | 46 | 2004 |
| Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells AN VZOROV, MI BUKRINSKY, VB GRIGORIEV, YYU TENTSOV, ... AIDS research and human retroviruses 7 (1), 29-36, 1991 | 38 | 1991 |
| Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization AN Vzorov, RW Compans Journal of Virology 74 (18), 8219-8225, 2000 | 37 | 2000 |
| Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins FS Quan, G Sailaja, I Skountzou, C Huang, A Vzorov, RW Compans, ... Vaccine 25 (19), 3841-3850, 2007 | 36 | 2007 |
| Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain Z Bu, L Ye, A Vzorov, D Taylor, RW Compans, C Yang Virology 328 (1), 62-73, 2004 | 35 | 2004 |
| Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity AN Vzorov, KM Gernert, RW Compans Virology 332 (1), 89-101, 2005 | 31 | 2005 |
| Induction of immune responses to SIV antigens by mucosally administered vaccines Z Moldoveanu, AN Vzorov, WQ Huang, J Mestecky, RW Compans AIDS research and human retroviruses 15 (16), 1469-1476, 1999 | 30 | 1999 |
| Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines CRW Vzorov AN, Wang L, Chen J, Wang BZ virology 489, 141, 2016 | 26 | 2016 |
| Prevention of poxvirus infection by tetrapyrroles ARM Chen-Collins, DW Dixon, AN Vzorov, LG Marzilli, RW Compans BMC Infectious Diseases 3, 1-10, 2003 | 25 | 2003 |
| Development of a rubella virus DNA vaccine SO Pougatcheva, ES Abernathy, AN Vzorov, RW Compans, TK Frey Vaccine 17 (15-16), 2104-2112, 1999 | 23 | 1999 |
| Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection AN Vzorov, A Weidmann, NL Kozyr, V Khaoustov, B Yoffe, RW Compans Retrovirology 4, 1-14, 2007 | 22 | 2007 |
| Immunogenicity of full length and truncated SIV envelope proteins AN VZOROV, D LEA-FOX, RW COMPANS Viral Immunology 12 (3), 205-215, 1999 | 21 | 1999 |
Richard CompansEmory University School of Medicine and Emory Vaccine CenterVerified email at emory.edu
